| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/28/2002 | WO2001090153A8 Reagents for cell selection and methods of use |
| 03/28/2002 | WO2001087062A3 Microinjection of cryoprotectants for preservation of cells |
| 03/28/2002 | WO2001085772A3 Virulence genes, proteins, and their use |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001083692A3 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/28/2002 | WO2001079459A3 Polypeptides having haloperoxidase activity |
| 03/28/2002 | WO2001077299A3 A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001077150A3 Serine-threonine kinase |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001070777A3 Leafy cotyledon2 genes and their uses |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001057224A3 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001055356A3 Human protein kinases and protein kinase-like enzymes |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001051606A3 Cell line for preparing and producing ovine adenovirus vectors |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2001029240A3 Regeneration |
| 03/28/2002 | WO2001027284A9 Recombinant megalomicin biosynthetic genes and uses thereof |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000062833A9 Cellular matrix system and use thereof |
| 03/28/2002 | WO2000060051A3 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 03/28/2002 | WO2000048621A9 Methods and compositions for regulating protein-protein interactions |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038465 Non-human animal mutants and methods for production of the same |
| 03/28/2002 | US20020038152 Compositions and methods for production and use of an injectable naturally secreted extracellular matrix |
| 03/28/2002 | US20020038003 Novel antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2002 | US20020037853 Polypeptides |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037847 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037586 Propagating preferential aggregates in nutrient broth; obtain aggregate, hold in preferential position, supply with nutrients, propagate aggregates, recover aggreagtes |
| 03/28/2002 | US20020037584 Use of nerve growth factor for the storage, culture or treatment of cornea |
| 03/28/2002 | US20020037583 Transforming cells with preferfential nucleotide sequences; obtain cells, transform, with vector, express vector, recover preferential proteins |
| 03/28/2002 | US20020037582 Potential effector for the grb7 family of signalling proteins |
| 03/28/2002 | US20020037576 Method of producing infectious reovirus |
| 03/28/2002 | US20020037575 Recombinant virus vectors |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037566 Apparatus for use in treating in injuries; wound healing agent |
| 03/28/2002 | US20020037565 Purifying and quantifying adenovirus by ion-exchange chromatography; for example, identifying different adenovirus serotypes |
| 03/28/2002 | US20020037557 Nucleotide sequences which code proteins for use in the treatment of nervous system, cardiovascular and liver disorders; for use in treatment of burns, traumatic injuries, surgery and ulcers |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037543 Purging of cells using viruses |
| 03/28/2002 | US20020037535 Contacting the cells (other than cancer cells and megakaryocyte progenitor cells) with a modified C-reactive protein or a mutant or mutant, modified C-reactive protein; in vitro or in vivo; |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037521 Method of identifying the source of genetic information in DNA |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | US20020037315 Transforming or transfecting cells with an anti-sense reagent capable of reducing Asp2 (Aspartyl protease 2) polypeptide production by reducing Asp2 transcription or translation in the cells for reducing cellular production of amyloid beta |
| 03/28/2002 | US20020037308 Angiogenic material and uses thereof |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
| 03/28/2002 | US20020037282 Universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 03/28/2002 | US20020037281 Methods of transducing neural cells using lentivirus vectors |
| 03/28/2002 | US20020037279 Delivery of bioactive compounds to an organism |
| 03/28/2002 | US20020037278 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 03/28/2002 | US20020037277 Treatment of brain damage |
| 03/28/2002 | US20020037276 Culturing a mammalian endocrine precursor cell in the presence of a phosphatidylinositol 3-kinase (PI3K) inhibitor whereby endocrine precursor cell differentiates into a cell having endocrine activity |
| 03/28/2002 | US20020037274 Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | DE10135996A1 Identifying metastatic tumor cells and screening for antitumor agents, comprises hybridization to specific cDNA sequences |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | DE10042535A1 Verfahren zur verbesserten Herstellung und Isolierung von trans-Dihydroxy-Cyclohexadien-Carbonsäuren und/oder deren Folgeprodukte sowie ein dazu geeigneter genetisch veränderter Organismus Method for improving the production and isolation of trans-dihydroxy-cyclohexadiene-carboxylic acids and / or their derivatives, and to a suitable genetically modified organism |
| 03/28/2002 | DE10042484A1 Preparing human cartilage implants, useful for repairing damaged joints, comprises culturing autologous chondrocytes in alginate gel at reduced oxygen partial pressure |
| 03/28/2002 | CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin |
| 03/28/2002 | CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | CA2423161A1 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | CA2423108A1 .beta.-catenin nuclear localizing protein |
| 03/28/2002 | CA2423104A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2423090A1 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2422740A1 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | CA2422631A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2422549A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/28/2002 | CA2422544A1 Conditionally replicating viral vectors and their use |
| 03/28/2002 | CA2422541A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421865A1 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | CA2421864A1 Transduction of dendritic cells using adenoviral vectors |
| 03/28/2002 | CA2421576A1 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | CA2421056A1 A polypeptide for use as a diagnostic marker for the presence of colon tumours |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | EP1191101A2 Polypeptides and nucleic acids encoding the same |
| 03/27/2002 | EP1191099A1 Novel polypeptide and dna thereof |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1191035A2 Three members of the cytokin-receptor class II family |
| 03/27/2002 | EP1191033A2 Compositions and methods for protein structural determinations |
| 03/27/2002 | EP1190726A2 Liquefied embolic materials capable of sol-gel phase transition and their use |
| 03/27/2002 | EP1190249A2 Compounds and methods to enhance raav transduction |